Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.9K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

129
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
129

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial transcriptomic profiling of ovarian clear cell carcinoma reveals heterogeneity in OXPHOS and EMT gradients.

Nature communications·2026
Same author

scDock: streamlining drug discovery targeting cell-cell communication via scRNA-seq analysis and molecular docking.

Bioinformatics (Oxford, England)·2026
Same author

Reactive oxygen species driven immune inflammation in systemic sclerosis: mechanisms and emerging therapeutics.

Drug discovery today·2026
Same author

Mass spectrometry-based human spatial omics: fundamentals, innovations, and applications.

Journal of biomedical science·2026
Same author

Transcriptional dynamics of CD8<sup>+</sup> T-cell exhaustion in immune checkpoint inhibitor resistance at single-cell resolution.

Molecular cancer·2025
Same author

Toward streamline variant classification: discrepancies in variant nomenclature and syntax for ClinVar pathogenic variants across annotation tools.

Human genomics·2025

Related Experiment Video

Updated: May 7, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K

scDrug+: predicting drug-responses using single-cell transcriptomics and molecular structure.

Yih-Yun Sun1, Chiao-Yu Hsieh2, Jian-Hung Wen3

  • 1Graduate Institute of Biomedical Electronics and Bioinformatics, National Taiwan University, Taiwan; Taiwan AI Labs, Taipei 10351, Taiwan.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|July 4, 2024
PubMed
Summary

This study introduces scDrug+, a new pipeline for predicting drug responses using transcriptomic data. It uniquely predicts responses for novel drugs by analyzing molecular structures, advancing precision medicine.

Keywords:
Drug-responsesMachine learningPrecision medicineSingle-cell transcriptomics

More Related Videos

An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects
07:37

An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects

Published on: January 9, 2020

9.4K
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.3K

Related Experiment Videos

Last Updated: May 7, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K
An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects
07:37

An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects

Published on: January 9, 2020

9.4K
Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
06:40

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets

Published on: February 23, 2024

1.3K

Area of Science:

  • Computational biology
  • Pharmacogenomics
  • Bioinformatics

Background:

  • Predicting drug responses from transcriptomic profiles is key for personalized medicine and prognosis.
  • Existing methods primarily focus on known drugs, leaving a gap for predicting responses to newly discovered therapeutics.

Purpose of the Study:

  • To develop a comprehensive pipeline, scDrug+, integrating single-cell analysis with drug-response prediction.
  • To enable prediction of drug responses for novel drugs based on their molecular structures.

Main Methods:

  • Development of scDrug+, an open-source pipeline available as a Docker container.
  • Integration of single-cell transcriptomic data analysis with molecular structure-based drug-response prediction.

Main Results:

  • scDrug+ successfully predicts drug responses, including for new drugs by analyzing molecular structures.
  • The pipeline ensures ease of deployment and reproducibility through its Docker container format.

Conclusions:

  • scDrug+ offers a novel approach to predict responses for both known and newly discovered drugs.
  • This tool enhances the potential of precision medicine by enabling more accurate drug response predictions.